SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:gup.ub.gu.se/289311"
 

Sökning: onr:"swepub:oai:gup.ub.gu.se/289311" > High mortality with...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00006734naa a2201501 4500
001oai:gup.ub.gu.se/289311
003SwePub
008240910s2019 | |||||||||||000 ||eng|
024a https://gup.ub.gu.se/publication/2893112 URI
024a https://doi.org/10.1530/eje-19-04642 DOI
040 a (SwePub)gu
041 a eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Valassi, E.4 aut
2451 0a High mortality within 90 days of diagnosis in patients with Cushing's syndrome: results from the ERCUSYN registry
264 1b Oxford University Press (OUP),c 2019
520 a Objective: Patients with Cushing's syndrome (CS) have increased mortality. The aim of this study was to evaluate the causes and time of death in a large cohort of patients with CS and to establish factors associated with increased mortality. Methods: In this cohort study, we analyzed 1564 patients included in the European Registry on CS (ERCUSYN); 1045 (67%) had pituitary-dependent CS, 385 (25%) adrenal-dependent CS, 89 (5%) had an ectopic source and 45 (3%) other causes. The median (IQR) overall follow-up time in ERCUSYN was 2.7 (1.2-5.5) years. Results: Forty-nine patients had died at the time of the analysis; 23 (47%) with pituitary-dependent CS, 6 (12%) with adrenal-dependent CS, 18 (37%) with ectopic CS and two (4%) with CS due to other causes. Of 42 patients whose cause of death was known, 15 (36%) died due to progression of the underlying disease, 13 (31%) due to infections, 7 (17%) due to cardiovascular or cerebrovascular disease and 2 due to pulmonary embolism. The commonest cause of death in patients with pituitary-dependent CS and adrenal-dependent CS were infectious diseases (n = 8) and progression of the underlying tumor (n = 10) in patients with ectopic CS. Patients who had died were older and more often males, and had more frequently muscle weakness, diabetes mellitus and ectopic CS, compared to survivors. Of 49 deceased patients, 22 (45%) died within 90 days from start of treatment and 5 (10%) before any treatment was given. The commonest cause of deaths in these 27 patients were infections (n = 10; 37%). In a regression analysis, age, ectopic CS and active disease were independently associated with overall death before and within 90 days from the start of treatment. Conclusion: Mortality rate was highest in patients with ectopic CS. Infectious diseases the commonest cause of death soon after diagnosis, emphasizing the need for careful vigilance at that time, especially in patients presenting with concomitant diabetes mellitus.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicin0 (SwePub)3022 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicine0 (SwePub)3022 hsv//eng
653 a transsphenoidal surgery
653 a disease
653 a morbidity
653 a management
653 a myopathy
653 a society
653 a Endocrinology & Metabolism
700a Tabarin, A.4 aut
700a Brue, T.4 aut
700a Feelders, R. A.4 aut
700a Reincke, M.4 aut
700a Netea-Maier, R.4 aut
700a Toth, M.4 aut
700a Zacharieva, S.4 aut
700a Webb, S. M.4 aut
700a Tsagarakis, S.4 aut
700a Chanson, P.4 aut
700a Pfeiffer, M.4 aut
700a Droste, M.4 aut
700a Komerdus, I.4 aut
700a Kastelan, D.4 aut
700a Maiter, D.4 aut
700a Chabre, O.4 aut
700a Franz, H.4 aut
700a Santos, A.4 aut
700a Strasburger, C. J.4 aut
700a Trainer, P. J.4 aut
700a Newell-Price, J.4 aut
700a Ragnarsson, Oskar,d 1971u Gothenburg University,Göteborgs universitet,Institutionen för medicin,Institute of Medicine4 aut0 (Swepub:gu)xragos
700a Ambroglo, A.4 aut
700a Aranda, G.4 aut
700a Arosio, M.4 aut
700a Balomenaki, M.4 aut
700a Beck-Peccoz, P.4 aut
700a Berr-Kirmair, C.4 aut
700a Bolanowski, M.4 aut
700a Bollerslev, J.4 aut
700a Thierry, B.4 aut
700a Carvalho, D.4 aut
700a Cavagnini, F.4 aut
700a Christ, E.4 aut
700a Demtroder, F.4 aut
700a Denes, J.4 aut
700a Dimopoulou, C.4 aut
700a Dreval, A.4 aut
700a Dusek, T.4 aut
700a Erdinc, E.4 aut
700a Evang, J. A.4 aut
700a Fazel, J.4 aut
700a Fica, S.4 aut
700a Ghigo, E.4 aut
700a Greenman, Y.4 aut
700a Greisa, V.4 aut
700a Halperin, I.4 aut
700a Hanzu, F. A.4 aut
700a Hermus, A.4 aut
700a Johannsson, G.4 aut
700a Kamenicky, P.4 aut
700a Kasperlik-Zaluska, A.4 aut
700a Kirchner, J.4 aut
700a Darko, K.4 aut
700a Kraljevic, I.4 aut
700a Kruszynska, A.4 aut
700a Lambrescu, I.4 aut
700a Lang, S.4 aut
700a Luger, A.4 aut
700a Marpole, N.4 aut
700a Martin, S.4 aut
700a Martinie, M.4 aut
700a Moros, O.4 aut
700a Newell-Price, J.4 aut
700a Orbetzova, M.4 aut
700a Paiva, I.4 aut
700a Giraldi, F. P.4 aut
700a Pereira, A. M.4 aut
700a Pickel, J.4 aut
700a Pirags, V.4 aut
700a Ragnarsson, O.4 aut
700a Reghina, A. D.4 aut
700a Riesgo, P.4 aut
700a Roberts, M.4 aut
700a Roerink, S.4 aut
700a Roig, O.4 aut
700a Rowan, C.4 aut
700a Rudenko, P.4 aut
700a Sahnoun, M. A.4 aut
700a Salvador, J.4 aut
700a Sigurjonsdottir, H. A.4 aut
700a Polovina, T. S.4 aut
700a Smith, R.4 aut
700a Stachowska, B.4 aut
700a Stalla, G.4 aut
700a Toke, J.4 aut
700a Ubina, E.4 aut
700a Vinay, S.4 aut
700a Wagenmakers, M.4 aut
700a Werner, S.4 aut
700a Young, J.4 aut
700a Zdunowski, P.4 aut
700a Zopf, K.4 aut
700a Zopp, S.4 aut
700a Zosin, I.4 aut
710a Göteborgs universitetb Institutionen för medicin4 org
773t European Journal of Endocrinologyd : Oxford University Press (OUP)g 181:5, s. 461-472q 181:5<461-472x 0804-4643x 1479-683X
856u https://eje.bioscientifica.com/downloadpdf/journals/eje/181/5/EJE-19-0464.pdf
8564 8u https://gup.ub.gu.se/publication/289311
8564 8u https://doi.org/10.1530/eje-19-0464

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy